Status:
UNKNOWN
Efficacy of Oxygen Therapy Delivered by Systems Using Oxygen-Saving Valves in COPD Patients
Lead Sponsor:
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Conditions:
LUNG DISEASES, OBSTRUCTIVE
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the efficacy of oxygen therapy delivered by systems using oxygen-saving valves or not (continuous oxygen). We aim to determine if systems using oxygen-saving va...
Eligibility Criteria
Inclusion
- COPD on necessity of long term oxygen therapy
- Able to give their written consent
Exclusion
- Unstable patients with COPD
- Patients with restrictive respiratory disease
- Patients with cardiac or neurologic disease contre-indicating the different evaluations
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01180803
Start Date
July 1 2010
End Date
December 1 2023
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fédération ANTADIR
Paris, France, 75006